Literature DB >> 6825632

New methods for detection of low levels of DNA damage in human populations.

W A Haseltine, W Franklin, J A Lippke.   

Abstract

The use of a postlabeling method to characterize and to detect infrequent base modifications in DNA is outlined. This method has the advantage that low levels of DNA modifications, approximately 1 modified base per 10(5) nucleotides, can be detected. Moreover, a broad spectrum of modification can be identified by using this methodology. The basis for the method involves transfer of a radioactive phosphate from the gamma position of ATP to the 5'-hydroxyl terminus of 3'-phosphoryl nucleotides that are derived from modified DNA by appropriate nuclease digestion. The second method involves use of a defined DNA sequence within human cells. The alpha sequence is used as a probe for DNA damage to specific nucleotides. The alpha DNA sequence is reiterated approximately 300,000 times in the human genome and exists in tandem arrays. It comprises approximately 1% of the entire genome. The reiterated sequence is sufficiently homogeneous to permit its use as a probe for a site specific in DNA damage. Examples of the application of both of these methodologies to DNA damage inflicted in human cells by chemicals and ultraviolet light are provided.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825632      PMCID: PMC1569071          DOI: 10.1289/ehp.834829

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  18 in total

1.  A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase.

Authors:  F Sanger; A R Coulson
Journal:  J Mol Biol       Date:  1975-05-25       Impact factor: 5.469

2.  3'-Phosphatase activity in T4 polynucleotide kinase.

Authors:  V Cameron; O C Uhlenbeck
Journal:  Biochemistry       Date:  1977-11-15       Impact factor: 3.162

3.  Specificity of substrate recognition by the EcoRI restriction endonuclease.

Authors:  B Polisky; P Greene; D E Garfin; B J McCarthy; H M Goodman; H W Boyer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Polynucleotide kinase from a T4 mutant which lacks the 3' phosphatase activity.

Authors:  V Cameron; D Soltis; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1978-03       Impact factor: 16.971

5.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Subunit structure of chromatin and the organization of eukaryotic highly repetitive DNA: recurrent periodicities and models for the evolutionary origins of repetitive DNA.

Authors:  J J Maio; F L Brown; P R Musich
Journal:  J Mol Biol       Date:  1977-12-15       Impact factor: 5.469

7.  Phosphorylation of nucleic acid by an enzyme from T4 bacteriophage-infected Escherichia coli.

Authors:  C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1965-07       Impact factor: 11.205

8.  Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).

Authors:  E Frei; J N Bickers; J S Hewlett; M Lane; W V Leary; R W Talley
Journal:  Cancer Res       Date:  1969-07       Impact factor: 12.701

9.  Repeating restriction fragments of human DNA.

Authors:  L Manuelidis
Journal:  Nucleic Acids Res       Date:  1976-11       Impact factor: 16.971

10.  Biomethylation of deoxyribonucleic acid in cultured human tumour cells (HeLa). Methylated bases other than 5-methylcytosine not detected.

Authors:  P D Lawley; A R Crathorn; S A Shah; B A Smith
Journal:  Biochem J       Date:  1972-06       Impact factor: 3.857

View more
  2 in total

1.  Studies on the mechanism of benzene toxicity.

Authors:  R Snyder; E Dimitriadis; R Guy; P Hu; K Cooper; H Bauer; G Witz; B D Goldstein
Journal:  Environ Health Perspect       Date:  1989-07       Impact factor: 9.031

2.  Chemical and biochemical dosimetry of exposure to genotoxic chemicals.

Authors:  G N Wogan; N J Gorelick
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.